Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation

Atrial fibrillation (AF) following cardiac surgery is an important factor contributing to postoperative morbidity. Transvenous, intracardial cardioversion (TIC) has been shown to be effective in the treatment of chronic AF, but is an invasive and cost-intensive procedure. However, TIC would definite...

Full description

Bibliographic Details
Main Authors: Fitzgerald Robert, Fritsch Stefan, Wislocki Wojciech, Oczenski Wolfgang, Waldenberger Ferdinand, Schwarz Sylvia
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2008-01-01
Series:Annals of Cardiac Anaesthesia
Subjects:
Online Access:http://www.annals.in/article.asp?issn=0971-9784;year=2008;volume=11;issue=2;spage=110;epage=114;aulast=Fitzgerald
id doaj-ce10a8ed050347748eb89f9e386ddf89
record_format Article
spelling doaj-ce10a8ed050347748eb89f9e386ddf892020-11-24T23:47:29ZengWolters Kluwer Medknow PublicationsAnnals of Cardiac Anaesthesia0971-97842008-01-01112110114Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillationFitzgerald RobertFritsch StefanWislocki WojciechOczenski WolfgangWaldenberger FerdinandSchwarz SylviaAtrial fibrillation (AF) following cardiac surgery is an important factor contributing to postoperative morbidity. Transvenous, intracardial cardioversion (TIC) has been shown to be effective in the treatment of chronic AF, but is an invasive and cost-intensive procedure. However, TIC would definitely be a beneficial approach if recurrence of AF following TIC is low and pharmacological treatment could be avoided. Thus, we hypothesised that TIC would be superior to conventional treatment with amiodarone with respect to the conversion rate and recurrence of AF. We compared TIC and conventional amiodarone therapy in a prospective, randomised and controlled trial in patients who developed AF following cardiac surgery. Twenty-three patients developed AF out of a total of 76 patients who gave written informed consent. Eighteen of these AF patients could be randomised into two equally sized groups to receive either an ALERT<sup> TM</sup> pulmonary artery catheter and TIC, or a standard pulmonary artery catheter and treatment with amiodarone. Haemodynamic parameters were registered before intervention to exclude pulmonary hypertension or fluid overload. Rates of cardioversion were compared by a Likelyhood ratio test. Out of the nine ALERT patients, AF in five cases converted to sinus rhythm (SR) with a median of two shocks (6 J). After 24 hours however, only two patients remained in sinus rhythm. On the other hand, six of the nine patients treated with amiodarone were still in SR after 24 hours. Whereas no difference was detectable in the conversion rate, persistence of SR following TIC was low. Thus, TIC without antiarrhythmic treatment is not recommendable for the treatment of postoperative AF.http://www.annals.in/article.asp?issn=0971-9784;year=2008;volume=11;issue=2;spage=110;epage=114;aulast=FitzgeraldAntiarrhythmic agentatrial fibrillationdefibrillation
collection DOAJ
language English
format Article
sources DOAJ
author Fitzgerald Robert
Fritsch Stefan
Wislocki Wojciech
Oczenski Wolfgang
Waldenberger Ferdinand
Schwarz Sylvia
spellingShingle Fitzgerald Robert
Fritsch Stefan
Wislocki Wojciech
Oczenski Wolfgang
Waldenberger Ferdinand
Schwarz Sylvia
Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
Annals of Cardiac Anaesthesia
Antiarrhythmic agent
atrial fibrillation
defibrillation
author_facet Fitzgerald Robert
Fritsch Stefan
Wislocki Wojciech
Oczenski Wolfgang
Waldenberger Ferdinand
Schwarz Sylvia
author_sort Fitzgerald Robert
title Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
title_short Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
title_full Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
title_fullStr Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
title_full_unstemmed Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
title_sort transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
publisher Wolters Kluwer Medknow Publications
series Annals of Cardiac Anaesthesia
issn 0971-9784
publishDate 2008-01-01
description Atrial fibrillation (AF) following cardiac surgery is an important factor contributing to postoperative morbidity. Transvenous, intracardial cardioversion (TIC) has been shown to be effective in the treatment of chronic AF, but is an invasive and cost-intensive procedure. However, TIC would definitely be a beneficial approach if recurrence of AF following TIC is low and pharmacological treatment could be avoided. Thus, we hypothesised that TIC would be superior to conventional treatment with amiodarone with respect to the conversion rate and recurrence of AF. We compared TIC and conventional amiodarone therapy in a prospective, randomised and controlled trial in patients who developed AF following cardiac surgery. Twenty-three patients developed AF out of a total of 76 patients who gave written informed consent. Eighteen of these AF patients could be randomised into two equally sized groups to receive either an ALERT<sup> TM</sup> pulmonary artery catheter and TIC, or a standard pulmonary artery catheter and treatment with amiodarone. Haemodynamic parameters were registered before intervention to exclude pulmonary hypertension or fluid overload. Rates of cardioversion were compared by a Likelyhood ratio test. Out of the nine ALERT patients, AF in five cases converted to sinus rhythm (SR) with a median of two shocks (6 J). After 24 hours however, only two patients remained in sinus rhythm. On the other hand, six of the nine patients treated with amiodarone were still in SR after 24 hours. Whereas no difference was detectable in the conversion rate, persistence of SR following TIC was low. Thus, TIC without antiarrhythmic treatment is not recommendable for the treatment of postoperative AF.
topic Antiarrhythmic agent
atrial fibrillation
defibrillation
url http://www.annals.in/article.asp?issn=0971-9784;year=2008;volume=11;issue=2;spage=110;epage=114;aulast=Fitzgerald
work_keys_str_mv AT fitzgeraldrobert transvenousintracardialcardioversionforthetreatmentofpostoperativeatrialfibrillation
AT fritschstefan transvenousintracardialcardioversionforthetreatmentofpostoperativeatrialfibrillation
AT wislockiwojciech transvenousintracardialcardioversionforthetreatmentofpostoperativeatrialfibrillation
AT oczenskiwolfgang transvenousintracardialcardioversionforthetreatmentofpostoperativeatrialfibrillation
AT waldenbergerferdinand transvenousintracardialcardioversionforthetreatmentofpostoperativeatrialfibrillation
AT schwarzsylvia transvenousintracardialcardioversionforthetreatmentofpostoperativeatrialfibrillation
_version_ 1725489435444772864